Micro Emerging Active

PFE TALZENNA 3. Faz Sonuçları

New narrative with limited coverage — still forming.

Puan
0,3
Hız
▲ 0,0
Makaleler
2
Kaynaklar
1

Sentiment Timeline

Event Timeline

Mar 28, 2026
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data Bullish
Mar 27, 2026
Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study … Neutral

Zaman Çizelgesi

İlk GörülmeMar 27, 2026
Son GüncellemeMar 27, 2026